IntegraGen S.A.
ALINT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -37.5% | -10.3% | -29.5% | – |
| Gross Profit | -€0 | €0 | -€0 | €0 |
| % Margin | -57% | 55.3% | -10.5% | 41.6% |
| EBITDA | -€0 | -€0 | -€0 | €0 |
| % Margin | -55.3% | -43.6% | -2.6% | 2.6% |
| Net Income | -€0 | -€0 | -€0 | €0 |
| % Margin | -54.9% | -3.4% | -2.5% | 1.4% |
| EPS Diluted | -0.21 | -0.021 | -0.017 | 0.014 |
| % Growth | -904.8% | -22.2% | -223.9% | – |
| Operating Cash Flow | -€0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | €0 | €0 | €0 |
| Free Cash Flow | -€0 | €0 | €0 | €0 |